At the 14th St. Gallen International Breast Cancer Conference 2015, Dr John Bartlett (Ontario Institute for Cancer Research, Toronto, Canada)…
Browsing: Acute Lymphoblastic Leukemia
At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Sibylle Loibl (German Breast Group, Neu-Isenburg, Germany) discusses recent…
At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Giuseppe Viale (European Institute of Oncology and University of…
At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York,…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Jia Ruan (Weill Cornell Medical College, New York, NY)…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Jia Ruan (Weill Cornell Medical College, New York, NY)…
Immunotherapy Forum Video #28: Doctors are still weighing the pros and cons of giving a cancer patient immunotherapy before or…
At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York,…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof John Gribben (Barts Cancer Institute, London, UK) and Prof…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof John Gribben (Barts Cancer Institute, London, UK) and Prof…
What should be the protocol for a rising PSA in an undiagnosed patient? Dr. Geo Espinosa of NYU-Langone Medical Center…
Dr Giuseppe Curigliano (European Institute of Oncology, Milan, Italy) provides an overview of immune approaches for the treatment of breast…
At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Giuseppe Viale (European Institute of Oncology and University of…
Dr. Geo Espinosa of NYU-Langone Medical Center explains the concept of Integrative Urology – the union of traditional and complementary…
Dr. Lluis Cecchini of the Hospital del Mar in Barcelona talks about the necessity for patients to become more involved…
The European Board of Urology recently certified the Urology Department of the Hospital del Mar in Barcelona as a urological…
The European Board of Urology recently certified the Urology Department of the Hospital del Mar in Barcelona as a urological…
Immunotherapy Forum Video #26: Drs. Jared Weiss and Matthew Hellmann answer questions from the audience following their presentations on immunotherapy…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Andrew Davies (University of Southampton, Southampton, UK) discusses a…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Marek Trn?ný (Charles University Hospital, Prague, Czech Republic) discusses…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Martin Dreyling (Ludwig-Maximilians University of Munich, Munich, Germany) discusses…
http://cancerGRACE.org/ Immunotherapy Forum Video #24: In Part 1 of 2 videos, Dr. Matthew Hellmann provides an overview of clinical trials…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Jia Ruan (Weill Cornell Medical College, New York, NY)…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Umberto Vitolo (Città della Salute e della Scienza di…
Ted Okon Executive Director of COA conducts an interview with Author Siddhartha Mukherjee, MD and Producer/Director Barak Goodman about the…
At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Charles Swanton (London Research Institute and University College London,…
At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Charles Swanton (London Research Institute and University College London,…
At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Charles Swanton (London Research Institute and University College London,…
At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Jonathan Ledermann (University College London, UK) discusses the collaboration…
At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Charles Swanton (London Research Institute and University College London,…
At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Jonathan Ledermann (University College London, UK) discusses recent advances…
Reports emerging data about molecular subtyping of early-stage breast cancer and patients’ risk of disease recurrence Steven C. Shivers, PhD.,…
Genomic Profiling, African-American Women and Breast Cancer Risk
Gene Called USP9X and Tamoxifen Resistance
Metastatic Breast Cancer – ER-Positive – Dr. Eitan Amir summarizes the latest updates in ER positive breast cancer from the…
Biology and Pathology Insights – Dr. John Bartlett presented this session as a summary of the topic from original research…
Dr. John Bartlett Theranostic multiparametric tests improve residual risk assessment in early luminal breast cancer
Dr. Eileen Rakovitch A large prospectively-designed study of the DCIS score: Predicting recurrence risk after local excision for ductal carcinoma…
Surgical Oncology Highlights summarized from the San Antonio Breast Cancer Symposium sessions, and presented by Dr. Jean-Francois Boileau as part…
Radiation Oncology Highlights – Dr. Eileen Rakovitch summarizing top results from the San Antonio Breast Cancer Symposium
Advances in Early Breast Cancer (Chemotherapy and Targeted Therapy as well as Endocrine Therapy) are discussed by Dr. Maureen Trudeau…
Neoadjuvant Treatment of Breast Cancer – A summary of the San Antonio Breast Cancer Symposium 2014, during the OncologyEducation licensed…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Umberto Vitolo (Città della Salute e della Scienza di…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Simon Rule (Derriford Hospital, Plymouth, UK) discusses recent studies…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Anton Hagenbeek (Academic Medical Center, Amsterdam, Netherlands) discusses recent…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Simon Rule (Derriford Hospital, Plymouth, UK) discusses recent advances…
A summary of the new uses of immunotherapy and biomarkers in the treatment of NSCLC by Dr. Nayer Rizvi
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof…
At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Christian Gisselbrecht (St. Louis Hospital, Paris, France) discusses recent…